CASI Pharmaceuticals
CASI
#9501
Rank
A$65.54 M
Marketcap
$4.24
Share price
-5.02%
Change (1 day)
-54.88%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$44.32 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$22.05 Million. In 2023 the company made an earning of -A$42.19 Million, an increase over its 2022 earnings that were of -A$59.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.32 Million5.04%
2023 -A$42.19 Million-29.55%
2022 -A$59.89 Million4.43%
2021 -A$57.34 Million-24.56%
2020 -A$76.01 Million4.74%
2019 -A$72.57 Million65.13%
2018 -A$43.95 Million155.07%
2017 -A$17.23 Million13.93%
2016 -A$15.13 Million31.18%
2015 -A$11.53 Million-72.5%
2014 -A$41.92 Million356.62%
2013 -A$9.18 Million-60.55%
2012 -A$23.27 Million218.41%
2011 -A$7.31 Million0.74%
2010 -A$7.26 Million-32.54%
2009 -A$10.76 Million-66.98%
2008 -A$32.57 Million-14.22%
2007 -A$37.97 Million7.04%
2006 -A$35.47 Million27.95%
2005 -A$27.72 Million4.51%
2004 -A$26.53 Million-15.84%
2003 -A$31.52 Million-55.29%
2002 -A$70.5 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$81.14 Million31.56%
1999 -A$61.68 Million145.56%
1998 -A$25.12 Million76.4%
1997 -A$14.24 Million36.92%
1996 -A$10.4 Million